Prognostic factors in pulmonary metastasized high-grade osteosarcoma

Pediatric Blood and Cancer

Volumn 54, Issue 2, 2010, Pages 216-221

  Buddingh, Emilie P ^a   Anninga, Jakob K ^a   Versteegh, Michel I M ^a   Taminiau, Antonie H M ^a   Egeler, R Maarten ^a   Van Rijswijk, Catherina S P ^a   Hogendoorn, Pancras C W ^a   Lankester, Arjan C ^a   Gelderblom, Hans ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone neoplasm; Metastasis; Osteosarcoma; Prognosis; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG METASTASIS; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SURGICAL TECHNIQUE;

ADULT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; OSTEOSARCOMA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 74849135253     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22293     Document Type: Article

References (29)

1. Fletcher CDM, Unni KK, Mertens F.World Health Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2002.
2. Aksnes LH, Hall KS, Folleraas G, et al. Management of high-grade bone sarcomas over two decades: The Norwegian Radium Hospital experience. Acta Oncol 2006;45:38-46.
3. Bacci G, Longhi A, Versari M, et al. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy-15-year experience in 789 patients treated at a single institution. Cancer 2006;106:1154-1161.
4. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002;20:776-790.
5. Lewis IJ, Nooij MA, Whelan J, et al. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst 2007;99: 112-128.
6. Meyers PA, Schwartz CL, Krailo MD, et al. Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival-A report from the Children's Oncology Group. J Clin Oncol 2008;26:633-638.
7. Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program. Cancer 2009;115:1531-1543.
8. Souhami RL, Craft AW, VanderEijken JW, et al. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: A study of the European Osteosarcoma Intergroup. Lancet 1997; 350:911-917.
9. Bacci G, Briccoli A, Longhi A, et al. Treatment and outcome of recurrent osteosarcoma: Experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy. Acta Oncol 2005;44:748-755.
10. Briccoli A, Rocca M, Salone M, et al. Resection of recurrent pulmonary metastases in patients with osteosarcoma. Cancer 2005;104:1721-1725.
11. Bacci G, Rocca M, Salone M, et al. High grade osteosarcoma of the extremities with lung metastases at presentation: Treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol 2008;98:415-420.
12. Kempf-Bielack B, Bielack SS, Jurgens H, et al. Osteosarcoma relapse after combined modality therapy: An analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol 2005;23:559-568.
13. Saeter G, Hoie J, Stenwig AE, et al. Systemic relapse of patients with osteogenic sarcoma. Cancer 1995;75:1084-1093.
14. Thompson RC, Cheng EY, Clohisy DR, et al. Results of treatment for metastatic osteosarcoma with neoadjuvant chemotherapy and surgery. Clin Orthop Relat Res 2002; 240-247.
15. Ward WG, Mikaelian K, Dorey F, et al. Pulmonary metastases of stage IIb extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol 1994;12:1849-1858.
16. Harting MT, Blakely ML, Jaffe N, et al. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma. J Pediatr Surg 2006;41:194-199.
17. Chou AJ, Merola PR,Wexler LH, et al. Treatment of osteosarcoma at first recurrence after contemporary therapy-The Memorial Sloan-Kettering Cancer Center Experience. Cancer 2005;104: 2214-2221.
18. Crompton BD, Goldsby RE, Weinberg VK, et al. Survival after recurrence of osteosarcoma: A 20-year experience at a single institution. Pediatr Blood Cancer 2006;47:255-259.
19. Gelderblom H, Sydes MR, Morgan RC, et al. Survival after recurrent osteosarcoma: Data from three European Osteosarcoma Intergroup (EOI) randomized controlled. J Clin Oncol (Meeting Abstracts) 2008;26:10505.
20. Bielack SS, Kempf-Bielack B, Branscheid D, et al. Second and subsequent recurrences of osteosarcoma: Presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. J Clin Oncol 2009;27:557-5565.
21. European and American Osteosarcoma Study Group. http://www.ctu.mrc.ac.uk/ euramos/, 2007.
22. Tronc F, Conter C, Marec-Berard P, et al. Prognostic factors and long-term results of pulmonary metastasectomy for pediatric histologies. Eur J Cardiothorac Surg 2008;34:1240-1246.
23. Van Rijk-Zwikker GL, Nooy MA, Taminiau A, et al. Pulmonary Metastasectomy in Patients with Osteosarcoma. Eur J Cardiothorac Surg 1991;5:406-409.
24. Kayton ML, Huvos AG, Casher J, et al. Computed tomographic scan of the chest underestimates the number of metastatic lesions in osteosarcoma. J Pediatr Surg 2006;41:200-204.
25. Petrilli AS, Gentil FC, Epelman S, et al. Increased survival, limb preservation, and prognostic factors for osteosarcoma. Cancer 1991;68:733-737.
26. Saeter G, Elomaa I, Wahlqvist Y, et al. Prognostic factors in bone sarcomas. Acta Orthop Scand 1997;68:156-160.
27. Dohi O, Hatori M, Suzuki T, et al. Sex steroid receptors expression and hormone-induced cell proliferation in human osteosarcoma. Cancer Sci 2008;99:518-523.
28. Maran A, Shogren KL, Benedikt M, et al. 2-methoxyestradiol-induced cell death in osteosarcoma cells is preceded by cell cycle arrest (vol 104, pg 1937, 2008). J Cell Biochem 2008;105: 1146.
29. Hauben EI,Weeden S, Pringle J, et al. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. Eur J Cancer 2002;38:1218-1225.